| Serial Number | 97089346 |
| Word Mark | ACNE DEFENSE |
| Filing Date | Saturday, October 23, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, November 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 20, 2024 |
| Goods and Services | Acne medications; Acne treatment preparations;Acne treatment sprays; Cream of tartar for pharmaceutical purposes; Dermatological pharmaceutical products; Dermatologicals; Herbal pills and mixes for the psychological benefit of cleansing one's karma; Herbal supplements; Herbal supplements for acne; Retinol for medical purposes for the treatment of acne; All purpose disinfectants; Anti-inflammatory sprays; Creams for dermatological use; First aid kits; Gels for dermatological use; Gels, creams and solutions for dermatological use; Liquid herbal supplements; Medical cleansers for skin and wounds; Medicated dermatological preparations and substances; Medicated balms for treatment of acne; Medicated creams for treating dermatological conditions; Medicated lotions for treating dermatological conditions; Medicated mouthwash; Medicated ointments for treating dermatological conditions; Medicated serums for treatment of acne; Medicated topical solution that increases the efficacy and percutaneous absorption of benzoyl peroxide; Medicinal herbal preparations; Medicinal alcohol; Medicinal preparations for stimulating hair growth; Natural herbal supplements; Niacinamide preparations for the treatment of acne; Parapharmaceutical products for use in dermatology; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, antivirals; Probiotic supplements; Skin lubricants for athletes to prevent skin chafing; Therapeutic medicated bath preparations; Therapeutic pharmaceutical for the treatment of acne; Topical dermatological preparations that treat insect bites and stings; Zinc supplement lozenges |
| NOT AVAILABLE | "ACNE" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 8, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Shree Saanvi USA LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Conyers, GA 30094 |
| Party Name | Shree Saanvi USA LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Conyers, GA 30094 |
| Event Date | Event Description |
| Wednesday, October 27, 2021 | NEW APPLICATION ENTERED |
| Monday, November 8, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, May 23, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, May 31, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 31, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, May 31, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 16, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 16, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 17, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 17, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, December 6, 2022 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, January 4, 2023 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Wednesday, January 4, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 4, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 4, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, February 19, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, February 19, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, February 20, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, March 16, 2023 | REPORT UNRESPONSIVE AMENDMENT - COMPLETED |
| Thursday, March 16, 2023 | NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Thursday, March 16, 2023 | NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED |
| Thursday, April 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 25, 2023 | ASSIGNED TO LIE |
| Friday, August 25, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 25, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 3, 2023 | FINAL REFUSAL WRITTEN |
| Tuesday, October 3, 2023 | FINAL REFUSAL E-MAILED |
| Tuesday, October 3, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, January 17, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, January 17, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 17, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, January 17, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, January 17, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 31, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, January 31, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 20, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, March 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 16, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, November 18, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, November 18, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |